BB Biotech AG
BBAGF News Today: Stay Updated with the Latest BB Biotech AG News in Real Time
Find BBAGF news now at Meyka AI. Stay informed with the latest BB Biotech AG stocks updates, including price news, market analysis, and expert insights.
ATX.AX Amplia Therapeutics ASX down 43% pre-market 08 Apr 2026: watch liquidity
ATX.AX stock falls 43% to A$0.15 pre-market on 08 Apr 2026; check volume, valuation and Meyka AI forecast
ALNEV.PA Neovacs (EURONEXT) drops 33% intraday to €0.0004: market risk ahead
Intraday: ALNEV.PA stock falls 33% to €0.0004 on EURONEXT; volume 5,270,481. Meyka AI outlook and forecast.
$0.16 PNXPF Planet Ventures Inc. (PNK) on 07 Apr 2026: top gainer, 3yr +36%
PNXPF stock jumps to USD 0.155 on 07 Apr 2026; Meyka AI projects 3yr target USD 0.21, +36% vs current price
Pre-market top loser: GBM.F Inovio Pharmaceuticals (XETRA) -34.80% 07 Apr 2026: catalyst timeline key
Pre-market top loser GBM.F stock down 34.80% on 07 Apr 2026. Quick GBM.F stock analysis, Meyka forecast and price targets.
Hercules Capital Posts Record $1.81B in Q1 Debt and Equity Commitments
Hercules Capital reported a record $1.81 billion in debt and equity commitments in Q1 2026, marking its strongest quarterly performance to date. This is a sharp rise from about $1.02 billion in Q1 2025, showing growing demand for venture debt. The funding supported 28 companies, including both new and existing clients. This surge comes at…
RLF.SW stock CHF 2.885 intraday 06 Apr 2026: earnings catalysts to watch
RLF.SW stock trades at CHF 2.885 intraday ahead of 08 Apr 2026 earnings; key metrics, Meyka grade and forecast
Neurocrine Biosciences Close to $2.5B Acquisition of Soleno Therapeutics
We’re seeing a major move in biotech today. Neurocrine Biosciences is close to completing a deal to acquire Soleno Therapeutics in a transaction worth more than $2.5 billion, potentially rising to about $2.9 billion in cash. This deal is one of the most notable biotech acquisitions so far in 2026, and it aligns with Neurocrine’s growth strategy…
Evotec SE (EVT.DE XETRA) 06 Apr 2026 earnings preview: valuation test ahead
EVT.DE stock trades at EUR 4.50 ahead of 08 Apr 2026 earnings; we review guidance risks, Meyka forecast and price targets for traders
Volume spike lifts QPTFF Quest PharmaTech (PNK) $0.03 Apr 04 2026: follow-up
QPTFF stock sees a volume surge to 225,625 shares on Apr 04 2026; short-term momentum and risks outlined